Ensayos clínicos

8.676 ensayos encontrados

CompletadoClinicalTrials.gov

Efficacy of BPS (Bacterial Pneumonia Score) Guided Antibiotic Use in Children With Community Acquired Pneumonia on Reducing Antibiotic Use as Compared to Standard Care Practice (Current Guidelines for CAP) in the Era of Pneumococcal Vaccine

INTERVENTIONALInicio: 1 de jul de 2013ID: NCT01875731

CompletadoClinicalTrials.gov

Characteristics and Outcomes of Patients With COVID-19-related Acute Respiratory Failure Treated With High-flow Nasal Oxygen and Awake-prone Position

OBSERVATIONALInicio: 15 de abr de 2020ID: NCT05178212

TerminadoFase 2ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

INTERVENTIONALInicio: 26 de dic de 2019ID: NCT04056611

ReclutandoFase 3ClinicalTrials.gov

Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

INTERVENTIONALInicio: 5 de abr de 2023ID: NCT05692180

CompletadoFase 3ClinicalTrials.gov

A Double Blind, Randomised, Placebo-controlled Trial to Evaluate the Dose-exposure and Safety of Nintedanib Per os on Top of Standard of Care for 24 Weeks, Followed by Open Label Treatment With Nintedanib of Variable Duration, in Children and Adolescents (6 to 17 Year-old) With Clinically Significant Fibrosing Interstitial Lung Disease

INTERVENTIONALInicio: 3 de dic de 2019ID: NCT04093024

TerminadoFase 2ClinicalTrials.gov

A Phase 2 Non-randomized, Open-label, Multi-cohort, Multi-center Study Assessing the Clinical Benefit of SAR444245 (THOR-707) Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Pleural Mesothelioma

INTERVENTIONALInicio: 23 de sept de 2021ID: NCT04914897

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Open-label, Multicenter, Randomized Study of Tarlatamab in Combination With Durvalumab vs Durvalumab Alone in Subjects With Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305)

INTERVENTIONALInicio: 5 de jun de 2024ID: NCT06211036

CompletadoClinicalTrials.gov

Ventilatory Variables in Subjects With Acute Respiratory Distress Syndrome Due to COVID-19

OBSERVATIONALInicio: 10 de feb de 2023ID: NCT05946525

ReclutandoFase 2ClinicalTrials.gov

A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants With Severe Asthma Who Completed the VALIANT Trial

INTERVENTIONALInicio: 21 de may de 2025ID: NCT06966479

CompletadoFase 1ClinicalTrials.gov

Phase 1 Study to Evaluate Safety, Tolerability and Immunogenicity of a New Recombinant Protein-based Vaccine (ARVAC CG) Against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), in a Population of Healthy Adult Volunteers Previously Vaccinated Against SARS-CoV-2 Virus.

INTERVENTIONALInicio: 20 de abr de 2022ID: NCT05656508

TerminadoFase 3ClinicalTrials.gov

A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

INTERVENTIONALInicio: 1 de jun de 2006ID: NCT00332826

DesconocidoClinicalTrials.gov

Incidence and Risk Factors for Developing Infections in Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae

OBSERVATIONALInicio: 1 de jul de 2022ID: NCT05492539

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) With a History of Exacerbations (PROSPERO).

INTERVENTIONALInicio: 6 de mar de 2023ID: NCT05742802

ReclutandoClinicalTrials.gov

Monitoring of Breathing Effort Through Pressure Time Product Measurement Using Airway Occlusion Pressure

OBSERVATIONALInicio: 1 de oct de 2023ID: NCT06040138

CompletadoClinicalTrials.gov

Abnormalities in Lung Computed Tomography and Physiological Alterations in Patients With Acute Respiratory Distress Syndrome

OBSERVATIONALInicio: 1 de ago de 2016ID: NCT02799940

Aún no reclutaClinicalTrials.gov

Analysis of Variability in the Management of Respiratory Infections in Hospitalized Patients Under 2 Years of Age Using Propensity Score Matching in Pediatric Inpatient Units"

OBSERVATIONALInicio: 1 de oct de 2025ID: NCT07202585

Activo, no reclutaFase 3ClinicalTrials.gov

An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

INTERVENTIONALInicio: 7 de mar de 2023ID: NCT05649748

DesconocidoClinicalTrials.gov

An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity

EXPANDED_ACCESSID: NCT01947608

ReclutandoClinicalTrials.gov

A Study to Evaluate the Accuracy of Primary Care Diagnosis Using Oscillometry and Fractional Exhaled Nitric Oxide for Asthma and COPD Versus Specialist Diagnosis in Patients With Suspected Asthma or COPD

OBSERVATIONALInicio: 26 de dic de 2025ID: NCT07245576

Por invitaciónFase 3ClinicalTrials.gov

A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)

INTERVENTIONALInicio: 23 de sept de 2019ID: NCT03683186